Leiden, The Netherlands, Aug. 6, 2013 (GLOBE NEWSWIRE) -- Prosensa Holding N.V. (NASDAQ: RNA) today announced that Hans GCP Schikan, Chief Executive Officer, will present a corporate overview at the Wedbush 2013 Life Sciences Management Access Conference in New York, NY on Tuesday, August 13, 2013 at 1:55pm ET. A live webcast of the presentation can be accessed through the Investor section of the Prosensa corporate website at http://ir.prosensa.eu/events.cfm and will be archived for 90 days.
About Prosensa Holding N.V.
Prosensa (NASDAQ: RNA) is a Dutch biotechnology company engaged in the discovery and development of RNA-modulating therapeutics for the treatment of genetic disorders. Its primary focus is on rare neuromuscular and neurodegenerative disorders with a large unmet medical need, including Duchenne muscular dystrophy, myotonic dystrophy and Huntington's disease.www.prosensa.com
CONTACT: Prosensa Holding N.V. Celia Economides Director IR & Corporate Communications Phone: +1 917 941 9059 Email: email@example.com The Trout Group Chad Rubin Phone: + 1 646 378 2900 Email: firstname.lastname@example.org